Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Cole, MD
Rutgers Cancer Institute of New Jersey
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
123 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Chus-Hopital Fleurimont
Sherbrooke, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Swiss Pediatric Oncology Group Geneva
Geneva, Switzerland
- Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
Birmingham, Alabama, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Children'S Hospital and Health Center - San Diego
San Diego, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Stanford Comprehensive Cancer Center - Stanford
Stanford, California, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Miami Children'S Hospital
Miami, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary'S Medical Center
West Palm Beach, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2004
- Primary completion
- 30 Sept 2007
- Completion
- —
- Last update posted
- 26 Jul 2013
- Registered enrollment
- 33
- Registry id
- NCT00070304
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.